​

Cara Therapeutics Ownership | Who Owns Cara Therapeutics?

OverviewForecastRevenueFinancialsChart

Cara Therapeutics Ownership Summary

Cara Therapeutics is owned by 0.02% institutional investors, 14.56% insiders, and 85.42% retail investors. Blackrock is the largest institutional shareholder, holding 1.36% of CARA shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.47% of its assets in Cara Therapeutics shares.

CARA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCara Therapeutics0.02%14.56%85.42%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock744.71K1.36%$192.13K
Bank of america corp /de/477.68K0.88%$123.24K
Goldman sachs group389.68K0.71%$100.54K
Northern trust369.71K0.68%$95.38K
Charles schwab investment management223.21K0.41%$57.59K
Morgan stanley69.28K0.13%$17.88K
B. riley wealth advisors61.61K0.11%$15.89K
Rhumbline advisers30.68K0.06%$7.91K
Rathbones group20.16K0.04%$7.16K
Barclays16.52K0.03%$4.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
B. riley wealth advisors61.61K0.00%$15.89K
Voya investment management---
Fidelis capital partners---
Parallel advisors---
Wr wealth planners---
Legal & general group---
Cypress capital management llc (wy)---
Fernwood investment management---
Renaissance---
Geode capital management---

Top Buyers

HolderShares% AssetsChange
Goldman sachs group389.68K-338.04K
Russell investments group13.14K-13.14K
B. riley wealth advisors61.61K0.00%5.96K
Royal bank of canada4.55K-3.05K
Macquarie group2.38K-2.38K

Top Sellers

HolderShares% AssetsChange
Blackrock744.71K--2.68M
Vanguard group---2.25M
Chescapmanager---1.70M
Farallon capital management---1.56M
Rosalind advisors---1.55M

New Positions

HolderShares% AssetsChangeValue
Macquarie group2.38K-2.38K$614.00

Sold Out

HolderChange
Dhjj financial advisors-2.00
Parallel advisors-4.00
Nelson, van denburg & campbell wealth management group-10.00
Corecap advisors-17.00
Us bancorp \de\-35.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-98.51%8,833-99.93%-0.00%--100.00%1-96.67%
Sep 30, 202466-17.50%13,467,508-23.85%242.34%12-61.29%2931.82%
Jun 30, 202480-20.00%17,686,050-25.10%321.70%31-13.89%22-33.33%
Mar 31, 2024100-11.50%23,611,820-2.99%432.17%36-21.74%33-2.94%
Dec 31, 2023113-10.32%24,339,169-10.27%441.78%46-11.54%34-19.05%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.35M2.47%-1.00
Vanguard Total Stock Mkt Idx Inv112.86K2.47%-
Disciplined Growth - Small Cap Growth811.50K1.48%811.50K
Vanguard Institutional Extnd Mkt Idx Tr53.81K1.18%-
Fidelity Extended Market Index21.03K0.46%-134.00
Disciplined Growth Small Cap Growth SP186.57K0.34%-
Vanguard Health Care ETF164.37K0.30%-408.00
NT R2000 Value Index Fund - NL125.06K0.23%-20.83K
NT R2000 Index Fund - NL121.34K0.22%-2.41K
NT R2000 Index Fund - DC - NL - 296.02K0.18%-2.26K

Recent Insider Transactions

DateNameRoleActivityValue
Feb 28, 2025Posner Christopher PRESIDENT AND CEOSell$2.77K
Feb 28, 2025Terrillion Scott SEC'Y; CHIEF COMPLIANCE & G.C.Sell$775.88
Feb 04, 2025Posner Christopher PRESIDENT AND CEOSell$1.76K
Nov 04, 2024Posner Christopher PRESIDENT AND CEOSell$1.06K
Aug 01, 2024Posner Christopher PRESIDENT AND CEOSell$1.45K

Insider Transactions Trends

DateBuySell
2025 Q1-1
2024 Q4-1
2024 Q3-1
2024 Q2-3
2024 Q1-5

CARA Ownership FAQ

Who Owns Cara Therapeutics?

Cara Therapeutics shareholders are primarily institutional investors at 0.02%, followed by 14.56% insiders and 85.42% retail investors. The average institutional ownership in Cara Therapeutics's industry, Biotech Stocks , is 68.48%, which Cara Therapeutics falls below.

Who owns the most shares of Cara Therapeutics?

Cara Therapeutics’s largest shareholders are Blackrock (744.71K shares, 1.36%), Bank of america corp /de/ (477.68K shares, 0.88%), and Goldman sachs group (389.68K shares, 0.71%). Together, they hold 2.95% of Cara Therapeutics’s total shares outstanding.

Does Blackrock own Cara Therapeutics?

Yes, BlackRock owns 1.36% of Cara Therapeutics, totaling 744.71K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 192.13K$. In the last quarter, BlackRock decreased its holdings by -2.677M shares, a -78.23% change.

Who is Cara Therapeutics’s biggest shareholder by percentage of total assets invested?

B. riley wealth advisors is Cara Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 61.61K Cara Therapeutics shares, valued at 15.9K$.

Who is the top mutual fund holder of Cara Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Cara Therapeutics shares, with 2.47% of its total shares outstanding invested in 1.35M Cara Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools